Orally and nasally induced tolerance studies in ocular inflammatory disease: guidance for future interventions.
The induction of both oral and nasal tolerance has been used in both experimental models of ocular disease and clinically. Initial work centered around the abrogation of experimental autoimmune uveitis using either one or two whole uveitogenic antigens. Other models of ocular disease have included a corneal transplant model, demonstrating that feeding splenocytes from the donor strain of rats enhanced corneal engraftment. Fragments of pertinent antigens have been shown to alter the expression of experimental uveitis and possibly human disease. A randomized, masked study in uveitis provided valuable information for future studies, demonstrating that single antigen feeding provided far better protection than the feeding of multiple antigens. This review will deal with animal and human studies in the treatment of ocular inflammatory disease with the goal of extracting from past experience how to construct a future study in humans.
Nussenblatt
Robert
R
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bldg. 10, Room 10S219, 10 Center Drive, Bethesda, MD 20892, USA. DrBob@nei.nih.gov
D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D051381:Rats; D014605:Uveitis / Q000188:drug therapy / Q000276:immunology*
D000941:Antigens